|
|
|
Volumn 46, Issue 8, 2000, Pages 531-536
|
|
Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients
a
|
|
Author keywords
Chlormadinone acetate; Diethylstilbestrol diphosphate; Disease flare; LH RH analogue; Prostate cancer
|
|
Indexed keywords
CHLORMADINONE ACETATE;
ESTROGEN;
FOSFESTROL;
GESTAGEN;
GONADORELIN AGONIST;
LEUPRORELIN;
LUTEINIZING HORMONE;
PROSTATE SPECIFIC ANTIGEN;
TESTOSTERONE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE EXACERBATION;
DRUG EFFECT;
DRUG INDUCED DISEASE;
HUMAN;
LUTEINIZING HORMONE BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
SLOW DRUG RELEASE;
TESTOSTERONE BLOOD LEVEL;
TREATMENT OUTCOME;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS, HORMONAL;
AUTACOIDS;
CHLORMADINONE ACETATE;
DIETHYLSTILBESTROL;
HUMANS;
LEUPROLIDE;
LUTEINIZING HORMONE;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PREMEDICATION;
PROGESTERONE CONGENERS;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TESTOSTERONE;
|
|
EID: 0033813769
PISSN: 00181994
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (12)
|
